Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 25 Issue 1, January 2024

Second-generation M1-polarized CAR macrophages

Induced pluripotent stem (iPS) cell-derived macrophages (iMACs) are being used to engineer CAR macrophages for immunotherapy. Zhang and colleagues design second-generation macrophage-specific CARs by integrating CD3ζ and TIR domains, resulting in M1-polarized CAR-iMACs with increased antitumor functions.

See Zhang et al.

Image credit: Jin Zhang, Zhejiang University. Cover design: Amie Fernandez

Obituary

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • T cells exist in many functional states, and dynamic transitions from one state to another affect the outcome of adoptive T cell therapy. FOXP1 and KLF2 are now identified as transcriptional regulators of the stemness of CD8+ CAR-T cells and the bifurcation of stem-like CD8+ CAR-T cells into effector and exhausted subsets, respectively.

    • Monica Casucci
    • Chiara Bonini
    • Eliana Ruggiero
    News & Views
  • Epithelial cells, macrophages and T cells are linked in a previously unknown regulatory circuit. Sensing of interferon-γ triggers antigen presentation by colonic epithelial cells, enabling T cells to lower extracellular ATP levels and reduce inflammation.

    • Oliver Pabst
    • Vuk Cerovic
    News & Views
  • Expressing chimeric antigen receptors (CARs) in macrophages has led to promising results in preclinical and clinical work. Now, induced pluripotent stem cells have been combined with a second-generation CAR to achieve macrophage rewiring and to broaden the applicability of the approach to solid malignancies.

    • Shifaa M. Abdin
    • Daniela Paasch
    • Nico Lachmann
    News & Views
  • BCG vaccination provides protection against unrelated viral infections. The vaccine induces protective integrated organ immunity through biphasic activation of innate and adaptive immune cells.

    • Maria Rescigno
    News & Views
Top of page ⤴

Research Briefings

  • We describe a system for introducing guide RNAs (gRNAs) to Cas9-expressing hematopoietic stem cells, which are used to generate mice with gene knockouts in the immune system. By using different gRNA-containing vectors and Cas9-expressing mice, we created systems for knockout of single genes or pairs of genes constitutively or inducibly.

    Research Briefing
  • Mouse macrophages express specialized genes particular to the organs they inhabit, but whether the same applies in humans is unclear. In human peritoneal fluid, we identified many macrophage phenotypes, including two specialized macrophage types that corresponded to distinct mouse peritoneal macrophages. However, their abundances were markedly different between species.

    Research Briefing
Top of page ⤴

Review Articles

  • In this Review, Netea and colleagues summarize the latest research that contributes to our understanding of the pathophysiology of sepsis, and how this contributes to a new treatment approach through personalized immunotherapy.

    • Evangelos J. Giamarellos-Bourboulis
    • Anna C. Aschenbrenner
    • Mihai G. Netea
    Review Article
  • In this Review, the authors describe the mechanisms that account for the generation and immune recognition of neoantigens that are not derived from DNA mutations, with a special focus on relevance to cancer and autoimmunity.

    • Lawrence J. Stern
    • Cristina Clement
    • Laura Santambrogio
    Review Article
Top of page ⤴

Articles

Top of page ⤴

Resources

Top of page ⤴

Technical Reports

Top of page ⤴

Search

Quick links